A phase II study of ASC-J9 cream in acne vulgaris

Journal of Drugs in Dermatology, Nov, 2007

Sponsored by AndroScience Corp. The purpose of this study is to evaluate if topical ASC-J9 cream is effective in treating acne.

Condition  Intervention        Phase

Acne       Drug: ASC-J9 cream  Phase II
Vulgaris   Drug: placebo

Study ID Numbers: ASC-J9-201

ClinicalTrials.gov Identifier: NCT00525499

Clinical Trial Review is designed to provide physicians with as much information as possible about drugs undergoing phase I, II, and III clinical testing. It is our goal to inform the reader of the up-to-date status of these drug trials before this information is available through standard channels. To participate in or learn more about these and additional trials, visit www.clinicaltrials.gov.